643 related articles for article (PubMed ID: 12907609)
1. Mice with alterations in both p53 and Ink4a/Arf display a striking increase in lung tumor multiplicity and progression: differential chemopreventive effect of budesonide in wild-type and mutant A/J mice.
Wang Y; Zhang Z; Kastens E; Lubet RA; You M
Cancer Res; 2003 Aug; 63(15):4389-95. PubMed ID: 12907609
[TBL] [Abstract][Full Text] [Related]
2. Cancer chemopreventive activity of a mixture of Chinese herbs (antitumor B) in mouse lung tumor models.
Zhang Z; Wang Y; Yao R; Li J; Yan Y; La Regina M; Lemon WL; Grubbs CJ; Lubet RA; You M
Oncogene; 2004 May; 23(21):3841-50. PubMed ID: 15021904
[TBL] [Abstract][Full Text] [Related]
3. Farnesyltransferase inhibitors are potent lung cancer chemopreventive agents in A/J mice with a dominant-negative p53 and/or heterozygous deletion of Ink4a/Arf.
Zhang Z; Wang Y; Lantry LE; Kastens E; Liu G; Hamilton AD; Sebti SM; Lubet RA; You M
Oncogene; 2003 Sep; 22(40):6257-65. PubMed ID: 13679864
[TBL] [Abstract][Full Text] [Related]
4. Tobacco smoke-induced lung tumorigenesis in mutant A/J mice with alterations in K-ras, p53, or Ink4a/Arf.
Wang Y; Zhang Z; Lubet R; You M
Oncogene; 2005 Apr; 24(18):3042-9. PubMed ID: 15846305
[TBL] [Abstract][Full Text] [Related]
5. Prevention of lung cancer progression by bexarotene in mouse models.
Wang Y; Zhang Z; Yao R; Jia D; Wang D; Lubet RA; You M
Oncogene; 2006 Mar; 25(9):1320-9. PubMed ID: 16247446
[TBL] [Abstract][Full Text] [Related]
6. Molecular alterations and lung tumors in p53 mutant mice exposed to cigarette smoke.
De Flora S; Balansky RM; D'Agostini F; Izzotti A; Camoirano A; Bennicelli C; Zhang Z; Wang Y; Lubet RA; You M
Cancer Res; 2003 Feb; 63(4):793-800. PubMed ID: 12591728
[TBL] [Abstract][Full Text] [Related]
7. Genetic and epigenetic alterations in lung tumors from bitransgenic Ki-rasG12C expressing mice.
Floyd HS; Jennings-Gee JE; Kock ND; Miller MS
Mol Carcinog; 2006 Jul; 45(7):506-17. PubMed ID: 16482519
[TBL] [Abstract][Full Text] [Related]
8. A germ-line p53 mutation accelerates pulmonary tumorigenesis: p53-independent efficacy of chemopreventive agents green tea or dexamethasone/myo-inositol and chemotherapeutic agents taxol or adriamycin.
Zhang Z; Liu Q; Lantry LE; Wang Y; Kelloff GJ; Anderson MW; Wiseman RW; Lubet RA; You M
Cancer Res; 2000 Feb; 60(4):901-7. PubMed ID: 10706103
[TBL] [Abstract][Full Text] [Related]
9. A strong candidate gene for the Papg1 locus on mouse chromosome 4 affecting lung tumor progression.
Zhang Z; Wang Y; Herzog CR; Liu G; Lee HW; DePinho RA; You M
Oncogene; 2002 Aug; 21(38):5960-6. PubMed ID: 12185599
[TBL] [Abstract][Full Text] [Related]
10. Genetic alterations of INK4alpha/ARF locus and p53 in human hepatocellular carcinoma.
Peng CY; Chen TC; Hung SP; Chen MF; Yeh CT; Tsai SL; Chu CM; Liaw YF
Anticancer Res; 2002; 22(2B):1265-71. PubMed ID: 12168936
[TBL] [Abstract][Full Text] [Related]
11. The role of Ink4a/Arf in ErbB2 mammary gland tumorigenesis.
D'Amico M; Wu K; Di Vizio D; Reutens AT; Stahl M; Fu M; Albanese C; Russell RG; Muller WJ; White M; Negassa A; Lee HW; DePinho RA; Pestell RG
Cancer Res; 2003 Jun; 63(12):3395-402. PubMed ID: 12810676
[TBL] [Abstract][Full Text] [Related]
12. A mouse model for tumor progression of lung cancer in ras and p53 transgenic mice.
Wang Y; Zhang Z; Lubet RA; You M
Oncogene; 2006 Feb; 25(8):1277-80. PubMed ID: 16247444
[TBL] [Abstract][Full Text] [Related]
13. Induction of invasive mouse skin carcinomas in transgenic mice with mutations in both H-ras and p53.
Zhang Z; Yao R; Li J; Wang Y; Boone CW; Lubet RA; You M
Mol Cancer Res; 2005 Oct; 3(10):563-74. PubMed ID: 16254190
[TBL] [Abstract][Full Text] [Related]
14. Effect of chemopreventive agents on separate stages of progression of benzo[alpha]pyrene induced lung tumors in A/J mice.
Estensen RD; Jordan MM; Wiedmann TS; Galbraith AR; Steele VE; Wattenberg LW
Carcinogenesis; 2004 Feb; 25(2):197-201. PubMed ID: 14578161
[TBL] [Abstract][Full Text] [Related]
15. The differential effects of mutant p53 alleles on advanced murine lung cancer.
Jackson EL; Olive KP; Tuveson DA; Bronson R; Crowley D; Brown M; Jacks T
Cancer Res; 2005 Nov; 65(22):10280-8. PubMed ID: 16288016
[TBL] [Abstract][Full Text] [Related]
16. Inactivation of the INK4A/ARF locus frequently coexists with TP53 mutations in non-small cell lung cancer.
Sanchez-Cespedes M; Reed AL; Buta M; Wu L; Westra WH; Herman JG; Yang SC; Jen J; Sidransky D
Oncogene; 1999 Oct; 18(43):5843-9. PubMed ID: 10557071
[TBL] [Abstract][Full Text] [Related]
17. The differential impact of p16(INK4a) or p19(ARF) deficiency on cell growth and tumorigenesis.
Sharpless NE; Ramsey MR; Balasubramanian P; Castrillon DH; DePinho RA
Oncogene; 2004 Jan; 23(2):379-85. PubMed ID: 14724566
[TBL] [Abstract][Full Text] [Related]
18. Effect of heterozygous loss of p53 on benzo[a]pyrene-induced mutations and tumors in DNA repair-deficient XPA mice.
van Oostrom CT; Boeve M; van Den Berg J; de Vries A; Dollé ME; Beems RB; van Kreijl CF; Vijg J; van Steeg H
Environ Mol Mutagen; 1999; 34(2-3):124-30. PubMed ID: 10529736
[TBL] [Abstract][Full Text] [Related]
19. Alterations of the INK4a-ARF gene locus in pleomorphic adenoma of the parotid gland.
Weber A; Langhanki L; Schütz A; Wittekind C; Bootz F; Tannapfel A
J Pathol; 2002 Nov; 198(3):326-34. PubMed ID: 12375265
[TBL] [Abstract][Full Text] [Related]
20. K-ras mutations in lung tumors from p53 mutant mice exposed to cigarette smoke.
Yao R; Wang Y; D'Agostini F; Izzotti A; Lubet RA; You M; De Flora S
Exp Lung Res; 2005 Mar; 31(2):271-81. PubMed ID: 15824025
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
